ArgusEye, a provider of innovative sensor solutions for real-time monitoring of biological systems, today announced the close of its funding, raising €2.8 million EUR (~£2.4 million GBP) bringing the total raised by the Company to €3.45 million EUR (~£3 million GPB).
Past and present FDA adcomm members weigh in on potential reforms
A majority of former and current FDA advisory committee members surveyed in July supported remote participation in meetings and better communication, as the FDA considers
August 14, 2024